Articles

Find an Article

Filter articles

Applied Filters

Showing 21 to 30 of 277 results

Algorithms—no; computer-implemented methods—yes

Mexico20-05-2019Alejandro Moreno Hernández

It is challenging but not impossible to protect software innovations in Mexico, according to Alejandro Moreno Hernández of Uhthoff, Gomez Vega & Uhthoff.

Conference preview: ChinaBio Partnering Forum 2019

China07-05-2019EBD Group

The 11th annual ChinaBio Partnering Forum global life science partnering event, which will be held on May 8 and 9 in Shanghai, China, is expected to attract more than 1,400 executives from 500-plus life sciences companies spanning an estimated 25 countries.

Conference preview: BIO-Europe Spring convenes in Vienna

Austria12-03-2019

The 13th annual BIO-Europe Spring 2019 global life science partnering event will be held March 25–27 in Vienna, Austria. Guadalupe Rodriguez and Kit Muller of EBD Group report.

Conference preview: 11th Pharma & Biotech Patent Litigation

EU, Netherlands13-12-2018

SPCs and trade secrets are just two issues set to be discussed at C5’s 11th Pharma & Biotech Patent Litigation, on February 26 and 27 in Amsterdam. LSIPR reports.

How Mexico applies the Budapest Treaty

Mexico29-11-2018Hector Chagoya and Mariana Gonzalez-Vargas

Hector Chagoya and Mariana Gonzalez-Vargas of Becerril, Coca & Becerril examine how Mexico applies the Budapest Treaty, which covers microorganisms in the patent process.

Generic competition: when one door closes, another opens

EU, US26-10-2018

With several major drugs set to face generic or biosimilar competition as patent protection expires, LSIPR analyses how well prepared their manufacturers are and how badly their sales may be affected.

The future of precision medicine part 3: translation from research to the clinic

UK, US23-10-2018Daniel Lim

The implementation of precision medicine represents a huge, possibly unprecedented, challenge to conventional clinical practice across the breadth of healthcare disciplines, says Daniel Lim of Kirkland & Ellis.

Gene-editing: a block on further development

EU22-10-2018

An EU court ruling on gene-editing regulation has sparked widespread concerns in the scientific and legal communities, as LSIPR finds out.

Samsung and HP: here come the techies

International, US15-10-2018

Samsung and HP are just two technology companies that have diversified and invested in the life sciences industry. What impact will this type of activity have on the sector and will it be beneficial in the long run? LSIPR finds out.

How the EPO treats personalised healthcare patents

EU12-10-2018Laurence Gainey

The patenting of personalised healthcare inventions has proved problematic in a 
number of jurisdictions, but various aspects of these inventions are patentable in Europe, as Laurence Gainey of HGF explains.

Showing 21 to 30 of 277 results

LSIPR